Pfizer's vaccine partner is being sued over alleged intellectual property rights in the use of mRNA technology.
CureVac said in a statement:"CureVac has filed a lawsuit in the German Regional Court in Dusseldorf against BioNTech SE and two of its subsidiaries, seeking fair compensation for infringement of a portfolio of CureVac's intellectual property rights."Development and production at the CureVac biopharmaceutical company that develops therapies based on messenger RNA in the German city of Tubingen. The company has brought a lawsuit before the Dusseldorf Regional Court.
"BioNTech's work is original, and we will vigorously defend it against all allegations of patent infringement. The CureVac biopharmaceutical company. The company has said that it is not seeking to slow down or restrict the production of the vaccine.CureVac Chief Executive Officer Franz-Werner Haas called for clarity over the quantity of the patented work used in the development of the BioNTech/Pfizer jab.
Development and production at the CureVac biopharmaceutical company that develops therapies based on messenger RNA in the German city of Tubingen. The company's own vaccine failed to generate effective enough results.It was the first mRNA vaccine against COVID-19 with a high rate of effectiveness, and is based on the ability of messenger RNA to initiate a production of protein that triggers an immune response in the human system.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Curevac sues BioNTech over COVID-19 vaccine's mRNA technologyCureVac is suing Pfizer's German partner BioNTech for alleged patent infringement related to the development of their mRNA vaccines against COVID-19.
Leer más »
COVID was third leading cause of death in 2020 and 2021COVID was the third leading cause of death in the U.S. in 2020 and 2021, accounting for 1 in 8 lives lost.
Leer más »
Judge reverses himself on LAUSD COVID vaccine mandateA judge ruled in favor of the father of a 12-year-old student who challenged the LAUSD’s student coronavirus vaccine mandate, finding that the resolution approving the directive clashes with …
Leer más »
Multipronged vaccine protects against COVID virus family members — even some still in hidingResearchers at Caltech have developed a vaccine designed to neutralize multiple coronaviruses at the same time.
Leer más »
NPR Cookie Consent and Choices
Leer más »